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For millions of years, microbes have coexisted with eukaryotic cells at the mucosal sur-
faces of vertebrates in a complex, yet usually harmonious symbiosis. An ever-expanding
number of reports describe how eliminating or shifting the intestinal microbiota has pro-
found effects on the development and functionality of the mucosal and systemic immune
systems. Here, we examine some of the mechanisms by which bacterial signals affect
immune homeostasis. Focusing on the strategies that microbes use to keep our immune
system healthy, as opposed to trying to correct the immune imbalances caused by dys-
biosis, may prove to be a more astute and efﬁcient way of treating immune-mediated
disease.
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INTRODUCTION
Higher organisms beneﬁt from their microbiota, which offers
nutritional and physiological advantages to the host in exchange
for a nutrient-rich habitat. Microbes (bacteria, archaea, viruses,
fungi,protozoans,etc.) reside on all mucosal surfaces of the body,
with the gut harboring by far the most numerous population.
Separating the microbial cells from the host is the intestinal bar-
rier, which serves as an interface for many complex interactions.
Two major components of the intestinal barrier are the intestinal
epithelium and the gut associated lymphoid tissue (GALT). This
tissue has the challenging dual task of selectively absorbing nutri-
ents from the intestinal lumen, while preventing microbial entry
andinfection.Themajorityof microbesthatresideintheintestine
arecommensalsanddonotposeathreattothehostundernormal
conditions. Thus,the host’s immune system must learn to tolerate
this enormous commensal antigenic load. One of the strategies
that the host utilizes to avoid an inﬂammatory response against
the microbiota is to remain“ignorant”to a portion of the micro-
bial antigens,by using the intestinal barrier,including the mucous
layer and immunoglobulin (Ig) A, to maintain these antigens at
a distance to the mucosal surface (Hansson and Johansson, 2010;
HooperandMacpherson,2010).However,itisnowclearthatthere
is also constant communication between microbial cells or signals
andhostcellreceptors,andthatmanyof theseinteractionsleadto
the development of immune tolerance toward bacterial antigens
(Hooper and Macpherson, 2010; Geuking et al., 2011).
Traditionally, it has been accepted that the evolution of the
mammalianimmunesystemhasbeendrivenbyselectivepressures
imposed by pathogenic bacteria (Matsunaga and Rahman, 1998).
For example, the emergence of jaws in cartilaginous ﬁsh matches
the appearance of antigen receptor speciﬁcity and immunological
memory in B and T cells, as well as the major histocompatibil-
ity complexes (MHC) I and II, all characteristic of the adaptive
immune system (Agrawal et al., 1998). Immunologists have spec-
ulated that the jaw gave organisms the ability to ingest harder
food sources that could damage the gut mucosa, likely increas-
ing their risk for infections. The nutritional advantages of having
a jaw allowed organisms to augment their body size and life
expectancy,increasing their risk for repeated microbial attack and
the necessity to develop immunological memory (Matsunaga and
Rahman, 1998). While this may be true for the emergence of
some features of the adaptive immune system, this view may not
apply to many other components of the immune system. First,
it does not take into account that the vast majority of inter-
actions that occur between the microbiota and the mammalian
immune system involve non-pathogenic bacteria. More impor-
tantly, commensals, as opposed to pathogens, do not limit the
host’slifespan,reproducibility,andconsequentverticalgenetrans-
fer, and actually probably enhance it. Thus, it is more likely that
commensalmicroorganismsposeastrongerevolutionarypressure
on the host’s immune system than pathogens,a view that we share
with others (McFall-Ngai,2007; Lee and Mazmanian, 2010).
The goal of this minireview is to describe some of the diverse
mechanisms of commensal–host communication in the mam-
malian intestine and to explore the effect that these have in
immune homeostasis within the intestine and systemically.
IMMUNE CONSEQUENCES OF AN AXENIC LIFE
The generation of germ-free mice has given us great insight into
the immune effects of a microbe-free life, the development of
the immune system during early microbial colonization, and the
effects of speciﬁc bacterial groups and species on the local and
systemic immune system.
The immune system is poorly developed in the absence of
microbes. Structurally, the aggregated lymphoid structures of the
GALT: mesenteric lymph nodes (MLNs), isolated lymphoid fol-
licles, cryptopatches, and Peyer’s patches are all underdeveloped
in germ-free mice (Mazmanian et al., 2005; Bouskra et al., 2008).
These mice exhibit decreased amounts of most cytokines, CD4+
Thelpercells,FoxP3+Tregs,Bcells,Th17cells,IgA,antimicrobial
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peptides, MHC class II, etc. (Moreau et al., 1978; Dobber et al.,
1992; Strauch et al., 2005; Ivanov et al., 2008; Niess et al., 2008;
Gaboriau-Routhiau et al., 2009; Round and Mazmanian, 2009),
and inoculating them with a single species of bacteria can revert
many of these defects (Umesaki et al., 1995; Mazmanian et al.,
2005).Gutbacteriaalsohavecriticaleffectsonthedevelopmentof
intestinalepithelialcells(IECs).IECsaretheﬁrstcellstoencounter
themicrobiotaandareabletointegratemostmicrobialsignalsand
dictate the tone of the immune response of the underlying lamina
propria immune cells (Rescigno, 2011). IECs express microbial
pattern recognition receptors (PRR) that bind to microbial sig-
nals and upregulate the expression of mucus,cytokines,and other
immunecomponents(Rescigno,2011).Intheabsenceof bacteria,
not only do these cells have a low expression of PRRs (Willing and
Van Kessel, 2007), they also fail to develop their typical microvilli
pattern and show a slow cell turnover rate (Abrams et al.,1963).
Not surprisingly, the functionality of the immune system in
axenic mice is very poor as well. Germ-free and even mono-
colonized mice do not develop oral tolerance (Rask et al., 2005).
Germ-freemiceandantibiotic-treatedmicearesigniﬁcantlymore
susceptible to infectious disease from several intestinal pathogens,
including Shigella ﬂexneri (Sprinz et al., 1961), Citrobacter roden-
tium (Wlodarska et al.,2011),Listeria monocytogenes (Zachar and
Savage, 1979), and Salmonella typhimurium (Nardi et al., 1989;
Sekirov et al.,2008; Ferreira et al.,2011). The microbiota can pre-
vent or ameliorate infection by direct microbial antagonism or by
indirectly promoting appropriate host immune defenses. Direct
microbial effects, also deﬁned as “colonization resistance” (van
der Waaij et al., 1971), include host receptor and nutrient com-
petition, and secretion of antimicrobial substances (Sekirov and
Finlay, 2009). The importance of these effects were demonstrated
in a study where transfer of a normal microﬂora, in the absence
of T and B cells, cleared infection with S. typhimurium (Endt
et al., 2010). This study highlights the importance of the compet-
itive pressures exerted by the microbiota as well as the role of the
innate immune response in enteric infections. In another study,
a fecal transplant from a mouse strain resistant to C. rodentium
was sufﬁcient to delay pathogen colonization and reduce mortal-
ity in a mouse strain lethally susceptible to infection. In addition,
antibiotic therapy increased disease severity in resistance mice,
suggesting that the difference in infection susceptibility between
thetwomicestrainscanbeexplained,atleastinpart,bydifferences
in microbiota composition (Willing et al.,2011).
A normal microbiota has also been shown to help clear
pathogens by stimulating several host immune effectors. In one
study, oral treatment with peptidoglycan from the intestinal
microbiota was effective in preventing pneumococcal sepsis in
mice. Levels of this bacterial membrane component in serum cor-
related with systemic neutrophil killing capacity and activation of
the innate immune receptor NOD1, indicating that signals from
themicrobiotatranslocateacrosstheintestinalbarrierandinteract
withsystemicimmunecells(Clarkeetal.,2010).Anotherexample
of how microbial-derived signals regulate the systemic immune
response comes from a study that showed that administration
of the TLR5 ligand, ﬂagellin, to antibiotic-treated mice inhib-
ited colonization with vancomycin resistant Enterococcus (VRE).
Intraperitonealinjectionof ﬂagellinupregulatedtheexpressionof
thebactericidallectinREGIIIγinIECsandPanethcellsinthesmall
intestine via activation of TLR5 in hematopoietic cells and secre-
tion of IL-22 (Kinnebrew et al., 2010). Flagellin stimulation has
also been shown to induce differentiation of non-speciﬁc IgA+
plasma cells via activation of TLR5 in intestinal dendritic cells
(Uematsuetal.,2008).ColonizationwiththemicroorganismBac-
teroides fragilis is sufﬁcient to prevent murine experimental colitis
induced by Helicobacter hepaticus. B. fragilis is coated with poly-
saccharide A (PSA) and this capsular component was shown to
suppress IL-17, increase IL-10 production and ameliorate disease
in this model (Mazmanian et al.,2008).
THE COMMENSAL MICROBIOTA BALANCES PRO AND
ANTI-INFLAMMATORY IMMUNE MECHANISMS
The Th17 immune response provides a good example of how
the microbiota mediates the balance between immune home-
ostasis and uncontrolled inﬂammation. Overproduction of Th17
cytokines IL-17 and IL-23 is associated with colitis (Atarashi et al.,
2008; Buonocore et al., 2010) and autoimmunity (Wen et al.,
2008; Lee et al., 2010; Wu et al., 2010); however, Th17 cells are
critical in controlling extracellular bacterial and fungal infections
(Smith et al., 2007; Wu et al., 2010). Induction of Th17 immu-
nity is crucial to prevent infection with C. rodentium, a murine
pathogen that induces similar inﬂammation to enteropathogenic
E. coli in humans (Wu et al., 2010). Thus, the right intensity of
Th17 response must be achieved in order to prevent microbial
attack and avoid uncontrolled inﬂammation. Segmented ﬁlamen-
tous bacteria (SFB) are an unclassiﬁed species that resides in the
murineileumandhasbeenshowntobeapotentstimulatorof the
Th17 response (Gaboriau-Routhiau et al., 2009; Wu et al., 2010).
Colonization with SFB induced the upregulation of cytokines,
antimicrobial peptides, and serum amyloid A (SAA), an acute
phase protein secreted during inﬂammation. SAA is believed to
promote the Th17 differentiation of CD4+ T cells (Ivanov et al.,
2009; Ather et al., 2011). Another mechanism that leads to Th17
differentiationistheproductionof commensal-derivedadenosine
5  triphosphate (ATP). ATP in the lamina propria stimulates den-
dritic cells to produce IL-6 and TGF-β, two cytokines necessary
for Th17 cell expansion (Atarashi et al., 2008). Not surprisingly,
microbial signals are also involved in limiting the Th17 immune
response. IECs produce IL-25, which inhibits IL-23 production
and prevents Th17 differentiation in response to the commensal
ﬂora (Zaph et al., 2008). In addition, oral administration of puri-
ﬁed PSA from B. fragilis downregulated the Th17 response and
induced propagation of Tregs in mice that develop autoimmune
encephalomyelitis.Thistreatmentwassufﬁcienttopreventdisease
in this animal model (Ochoa-Reparaz et al., 2010). Collectively,
these ﬁndings show how the microbiota produces inﬂammatory
and tolerogenic signals in order to achieve immune homeostasis,
a state that is favorable for both the microbiota and the host.
It is still unknown how certain microbes induce a pro-
inﬂammatory response and others a tolerogenic one, but due to
the central role that Treg cells have in regulating inﬂammatory
responses (Figure 1), one could speculate that microbes manip-
ulate the Treg cell response as a strategy to regulate immune
responses towards them. But how do Treg cells perform such task?
These cells are selected in the thymus for their ability to suppress
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FIGURE 1 |The microbiota helps to maintain immune
homeostasis by stimulating different arms of theT cell response.
(A) SFB is a potent inducer ofTh17 cells, whereas pathogens like S.
typhimurium induce an effectorTh1 response. PSA from B. fragilis
stimulates the differentiation of FoxP3+T cells, which downregulate
the pro-inﬂammatoryTh1 andTh17 responses. (B) Different
environmental and host-derived factors are known to cause dysbiosis.
Imbalances in the intestinal microbiota can favorTh17
pro-inﬂammatoryT cells over regulatory FoxP3+T cells, inducing
inﬂammatory response that can damage the intestinal epithelium. In
a genetically predisposed host this can lead to chronic inﬂammatory
disease, such as IBD or autoimmunity.
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T cells with a high afﬁnity to self-MHC molecules, thus prevent-
ing autoimmune responses,but it is still unknown how these cells
differentiate between pathogens or commensal pathogen signals.
One explanation may be that the antigens from the commensal
microbiota are used to train naïve T cells to differentiate into Treg
cells. A recent study provides evidence that this may in fact occur.
Analysis of several repertoires of T cell receptor (TCR) α chain
revealed that the TCRs from FoxP3+ Treg cells within the colonic
lamina propria are highly heterogeneous compared to Treg cells
from effector/memory T cells in the lamina propria and from
Treg cells from secondary lymphoid organs. Moreover, the study
showed that the mouse microbiota was essential for the induction
ofthisparticularpopulationofcolonicTregcellsfromnaïveTcells,
implying that there may be post-thymic mechanisms of immune
cell education that occur peripherally via interactions with the
commensal microbiota (Lathrop et al., 2011). This implies that
the immune system may have evolved to rely on the microbiota to
complete the training of a speciﬁc population of immune cells.
DISSECTING THE GUT MICROBIOTA
Although our knowledge of the immune effects caused by the
microbiota is growing,much less is known about what constitutes
a normal microbiota and which groups of microorganisms are
beneﬁcial or detrimental to immune homeostasis. Sequencing-
based studies have substantially increased our knowledge of the
ecology of the mammalian intestine, although it is safe to assume
thatwearelikelyattheearlystagesofcomprehendingthiscomplex
population.
Analyses of the human gut microbiota have yielded several
important ﬁndings. First, although there is great inter-individual
variability at the species level, there appears to be low variabil-
ity between individuals at the phylum level (Eckburg et al., 2005;
Turnbaugh et al., 2009). The human gut is colonized by mainly
three phyla: Firmicutes, Bacteroidetes, and Actinobacteria. The
most predominant bacterial families are Ruminococcaceae,Lach-
nospiraceae,Eubacteriaceae,andBacteroidaceae,inwhathasbeen
deﬁned as the “core members of the microbiota” (Tap et al.,
2009). Genetics and environmental factors, such as birth deliv-
ery method, diet, and antibiotic use have an important role in
establishing the composition of the microbiota (Ley et al., 2006;
Penders et al.,2006;Adlerberth,2008; Benson et al.,2010;Willing
et al., 2010). Compositional studies have also shown that cer-
tain members of the ﬂora may be indicative of disease states.
For example, the bacterium Faecalibacterium prausnitzii, a mem-
ber of the Ruminococcaceae family is absent in samples from
Crohn’s disease (CD) patients (Sokol et al., 2008; Willing et al.,
2009). Moreover, amelioration of disease with the anti TNF anti-
body, inﬂiximab, allows F. prausnitzii to recolonize (Swidsinski
et al., 2008). Furthermore, F. prausnitzii levels do not change in
patients with ulcerative colitis, a disease characterized by Th2-
type inﬂammation, suggesting that this microorganism is partic-
ularly susceptible to Th1 (predominant in CD) and not Th2-type
inﬂammation.
A recent study analyzed the human fecal microbiota of 39
individuals from 6 different developed countries and found
that there are three distinct ecosystems in the human gut,
or “enterotypes.” The genus Bacteroides is highly abundant in
enterotype 1, Prevotella is very common for enterotype type 2
andRuminococcus inenterotype3.Althoughthefunctionalimpli-
cations of all enterotypes are still under study, it seems that
each enterotype favors the synthesis of certain metabolic prod-
ucts. Enterotype 1 ecosystem favors the production of enzymes
involved in biotin synthesis, whereas enterotype 2 species pro-
duce more enzymes for thiamine synthesis (Arumugam et al.,
2011). Another study examined the fecal microbiota of 98 indi-
viduals and showed that samples clustered into two of the previ-
ously described enterotypes: Bacteroides-rich and Prevotella-rich
ecosystems. Interestingly, the authors were able to correlate these
enterotypes with long-term diets. Individuals with high animal
fat in their diet clustered in the Bacteroides enterotype, whereas
diets high in carbohydrate clustered in the Prevotella enterotype.
A short-term intervention with a carbohydrate-rich diet did not
cause a switch from Bacteroides into Prevotella enterotypes, sug-
gesting that they reﬂect long-term diet conditions (Wu et al.,
2011). There are still many unanswered questions regarding the
correlation between intestinal enterotypes and the immune sta-
tus of the host, as well as the possibility that there are more than
three enterotypes or subenterotypes. However, the compositional
classiﬁcation of the human gut microbiota into functional ecosys-
tems has enormous potential as a marker of disease and as a
treatment.
FINAL REMARKS
The immune environment of the gut is characterized by toler-
ance.Toachievethisstate,hostimmunecellsmustlearntoexhibit
a tolerogenic behavior toward most microbial antigens. Thus,
besides protecting the host from microbial attack, post-natal bac-
terial colonization likely serves the immune system with another
important function: to be used as the second “training ground”
for some naïve immune cells. Although this view poses a caveat
to the traditional view of the main function of immune system –
to distinguish between self and non-self – it may explain why
the majority of the bacterial antigens in the gut are perceived as
self-antigens.
More mechanisms on how and what components of the com-
mensal microbiota affect mucosal and systemic immunity will
undoubtedly continue to be found. This will not only expand our
viewof ourmicrobiotaasanintegralpartof ourbodies(Gilletal.,
2010), but it also opens the real possibility of manipulating spe-
ciﬁcfunctionsofthemicrobiotatotuneimmunedefectsthatcause
infectious, inﬂammatory, or autoimmune disease. Learning from
thestrategiesthatthemicrobiotausetobalancethedifferentarms
of the immune response and using them to overcome disease may
provetobemoreefﬁcientthanmodifyingtheimmuneimbalances
that originate from defective genes and microbial dysbiosis.
ACKNOWLEDGMENTS
The authors would like to thank Marta Wlodarska, Dr. Benjamin
Willing, and Dr. Jerôme Tourret for the critical revision of this
manuscript, and Fern Ness for the artwork for Figure 1.T h e
Finlay laboratory is supported by operating grants from Cana-
dian Institutes of Heath Research (CIHR), the Crohn and Colitis
Foundation of Canada (CCFC),and the Howard Hughes Medical
Institute (HHMI).
Frontiers in Immunology | Molecular Innate Immunity March 2012 | Volume 3 | Article 33 | 4Arrieta and Finlay The commensal microbiota drives immune homeostasis
REFERENCES
Abrams,G.D.,Bauer,H.,andSprinz,H.
(1963).Inﬂuenceofthenormalﬂora
onmucosalmorphologyandcellular
renewal in the ileum. A comparison
of germ-freeandconventionalmice.
Lab. Invest. 12, 355–364.
Adlerberth, I. (2008). Factors inﬂuenc-
ing the establishment of the intesti-
nal microbiota in infancy. Nestle
Nutr. Workshop Ser. Pediatr. Pro-
gram. 62, 13–29; discussion 29–33.
Agrawal,A.,Eastman,Q.M.,andSchatz,
D. G. (1998). Transposition medi-
ated by RAG1 and RAG2 and its
implications for the evolution of
the immune system. Nature 394,
744–751.
Arumugam, M., Raes, J., Pelletier, E.,
Le Paslier, D., Yamada, T., Mende,
D. R., Fernandes, G. R., Tap, J.,
Bruls, T., Batto, J. M., Bertalan, M.,
Borruel, N., Casellas, F., Fernandez,
L., Gautier, L., Hansen, T., Hattori,
M., Hayashi, T., Kleerebezem, M.,
Kurokawa, K., Leclerc, M., Levenez,
F., Manichanh, C., Nielsen, H. B.,
Nielsen, T., Pons, N., Poulain, J.,
Qin,J.,Sicheritz-Ponten,T.,Tims,S.,
Torrents, D., Ugarte, E., Zoetendal,
E. G., Wang, J., Guarner, F., Ped-
ersen, O., De Vos, W. M., Brunak,
S., Dore, J., Antolin, M., Artigue-
nave, F., Blottiere, H. M., Almeida,
M., Brechot, C., Cara, C., Chervaux,
C.,Cultrone,A.,Delorme,C.,Denar-
iaz, G., Dervyn, R., Foerstner, K.
U., Friss, C., Van De Guchte, M.,
Guedon, E., Haimet, F., Huber, W.,
Van Hylckama-Vlieg, J., Jamet, A.,
Juste,C.,Kaci,G.,Knol,J.,Lakhdari,
O., Layec, S., Le Roux, K., Maguin,
E., Merieux, A., Melo Minardi, R.,
M’Rini, C., Muller, J., Oozeer, R.,
Parkhill,J.,Renault,P.,Rescigno,M.,
Sanchez, N., Sunagawa, S., Torrejon,
A., Turner, K., Vandemeulebrouck,
G.,Varela,E.,Winogradsky,Y.,Zeller,
G., Weissenbach, J., Ehrlich, S. D.,
and Bork, P. (2011). Enterotypes of
the human gut microbiome. Nature
473, 174–180.
Atarashi, K., Nishimura, J., Shima, T.,
Umesaki,Y.,Yamamoto, M., Onoue,
M., Yagita, H., Ishii, N., Evans,
R., Honda, K., and Takeda, K.
(2008). ATP drives lamina propria
T(H)17 cell differentiation. Nature
455, 808–812.
Ather, J. L., Ckless, K., Martin, R.,
Foley, K. L., Suratt, B. T., Boyson,
J. E., Fitzgerald, K. A., Flavell, R.
A., Eisenbarth, S. C., and Poyn-
ter, M. E. (2011). Serum amyloid
A activates the NLRP3 inﬂamma-
some and promotes Th17 allergic
asthma in mice. J. Immunol. 187,
64–73.
Benson, A. K., Kelly, S. A., Legge, R.,
Ma, F., Low, S. J., Kim, J., Zhang,
M., Oh, P. L., Nehrenberg, D., Hua,
K., Kachman, S. D., Moriyama, E.
N., Walter, J., Peterson, D. A., and
Pomp,D.(2010).Individualityingut
microbiota composition is a com-
plexpolygenictraitshapedbymulti-
ple environmental and host genetic
factors. Proc. Natl. Acad. Sci. U.S.A.
107, 18933–18938.
Bouskra, D., Brezillon, C., Berard, M.,
Werts, C., Varona, R., Boneca, I. G.,
and Eberl, G. (2008). Lymphoid tis-
sue genesis induced by commensals
through NOD1 regulates intestinal
homeostasis. Nature 456, 507–510.
Buonocore, S., Ahern, P. P., Uhlig, H.
H., Ivanov, Ii, Littman, D. R., Maloy,
K. J., and Powrie, F. (2010). Innate
lymphoid cells drive interleukin-23-
dependent innate intestinal pathol-
ogy. Nature 464, 1371–1375.
Clarke, T. B., Davis, K. M., Lysenko, E.
S., Zhou, A. Y., Yu, Y., and Weiser, J.
N. (2010). Recognition of peptido-
glycanfromthemicrobiotabyNod1
enhances systemic innate immunity.
Nat. Med. 16, 228–231.
Dobber, R., Hertogh-Huijbregts, A.,
Rozing,J.,Bottomly,K.,andNagelk-
erken, L. (1992). The involvement
of the intestinal microﬂora in the
expansion of CD4+ T cells with a
naive phenotype in the periphery.
Dev. Immunol. 2, 141–150.
Eckburg, P. B., Bik, E. M., Bernstein, C.
N., Purdom, E., Dethlefsen, L., Sar-
gent,M.,Gill,S.R.,Nelson,K.E.,and
Relman, D. A. (2005). Diversity of
thehumanintestinalmicrobialﬂora.
Science 308, 1635–1638.
Endt,K.,Stecher,B.,Chaffron,S.,Slack,
E., Tchitchek, N., Benecke, A., Van
Maele, L., Sirard, J. C., Mueller,
A. J., Heikenwalder, M., Macpher-
son, A. J., Strugnell, R., Von Mer-
ing, C., and Hardt, W. D. (2010).
The microbiota mediates pathogen
clearance from the gut lumen
afternon-typhoidalSalmonella diar-
rhea. PLoS Pathog. 6, e1001097.
doi:10.1371/journal.ppat.1001097
Ferreira, R. B., Gill, N., Willing, B. P.,
Antunes,L.C.,Russell,S.L.,Croxen,
M. A., and Finlay, B. B. (2011). The
intestinal microbiota plays a role in
Salmonella-induced colitis indepen-
dent of pathogen colonization. PLoS
ONE 6, e20338. doi:10.1371/jour-
nal.pone.0020338
Gaboriau-Routhiau, V., Rakotobe, S.,
Lecuyer, E., Mulder, I., Lan, A.,
Bridonneau, C., Rochet, V., Pisi, A.,
De Paepe, M., Brandi, G., Eberl,
G., Snel, J., Kelly, D., and Cerf-
Bensussan, N. (2009). The key role
of segmented ﬁlamentous bacteria
inthecoordinatedmaturationofgut
helper T cell responses. Immunity
31, 677–689.
Geuking,M.B.,Cahenzli,J.,Lawson,M.
A., Ng, D. C., Slack, E., Hapfelmeier,
S., Mccoy, K. D., and Macpherson,
A. J. (2011). Intestinal bacterial col-
onization induces mutualistic regu-
latoryTcellresponses.Immunity 34,
794–806.
Gill, N., Wlodarska, M., and Finlay, B.
B. (2010). The future of mucosal
immunology:studyinganintegrated
system-wide organ. Nat. Immunol.
11, 558–560.
Hansson, G. C., and Johansson, M. E.
(2010). The inner of the two Muc2
mucin-dependent mucus layers in
c o l o ni sd e v o i do fb a c t e r i a .Gut
Microbes 1, 51–54.
Hooper, L. V., and Macpherson, A.
J. (2010). Immune adaptations
that maintain homeostasis with
the intestinal microbiota. Nat. Rev.
Immunol. 10, 159–169.
Ivanov, I. I., Atarashi, K., Manel, N.,
Brodie, E. L., Shima, T., Karaoz, U.,
Wei, D., Goldfarb, K. C., Santee, C.
A., Lynch, S. V., Tanoue, T., Imaoka,
A., Itoh, K., Takeda, K., Umesaki,
Y., Honda, K., and Littman, D. R.
(2009). Induction of intestinal Th17
cells by segmented ﬁlamentous bac-
teria. Cell 139, 485–498.
Ivanov, I. I., Frutos Rde, L., Manel, N.,
Yoshinaga, K., Rifkin, D. B., Sartor,
R. B., Finlay, B. B., and Littman,
D. R. (2008). Speciﬁc microbiota
direct the differentiation of IL-
17-producing T-helper cells in the
mucosa of the small intestine. Cell
Host Microbe 4, 337–349.
Kinnebrew,M.A.,Ubeda,C.,Zenewicz,
L. A., Smith, N., Flavell, R. A.,
and Pamer, E. G. (2010). Bacterial
ﬂagellin stimulates Toll-like recep-
tor 5-dependent defense against
vancomycin-resistant Enterococcus
infection.J.Infect.Dis.201,534–543.
Lathrop, S. K., Bloom, S. M., Rao, S.
M.,Nutsch,K.,Lio,C.W.,Santacruz,
N., Peterson, D. A., Stappenbeck, T.
S., and Hsieh, C. S. (2011). Periph-
eraleducationoftheimmunesystem
by colonic commensal microbiota.
Nature 478, 250–254.
Lee,Y.K.,andMazmanian,S.K.(2010).
Has the microbiota played a critical
role in the evolution of the adap-
tive immune system? Science 330,
1768–1773.
Lee, Y. K., Menezes, J. S., Umesaki,
Y., and Mazmanian, S. K. (2010).
Microbes and health Sackler col-
loquium: proinﬂammatory T-cell
responses to gut microbiota pro-
mote experimental autoimmune
encephalomyelitis. Proc. Natl.
Acad. Sci. U.S.A. 108(Suppl. 1),
4615–4622.
Ley,R.E.,Peterson,D.A.,andGordon,J.
I. (2006). Ecological and evolution-
ary forces shaping microbial diver-
sityinthehumanintestine.Cell 124,
837–848.
Matsunaga, T., and Rahman, A.
(1998). What brought the adaptive
immune system to vertebrates? The
jaw hypothesis and the seahorse.
Immunol. Rev. 166, 177–186.
Mazmanian, S. K., Liu, C. H., Tziana-
bos, A. O., and Kasper, D. L. (2005).
Animmunomodulatorymoleculeof
symbiotic bacteria directs matura-
tionof thehostimmunesystem.Cell
122, 107–118.
Mazmanian, S. K., Round, J. L., and
Kasper, D. L. (2008). A microbial
symbiosis factor prevents intestinal
inﬂammatory disease. Nature 453,
620–625.
McFall-Ngai, M. (2007). Adaptive
immunity: care for the community.
Nature 445, 153.
Moreau, M. C., Ducluzeau, R., Guy-
Grand,D.,andMuller,M.C.(1978).
Increaseinthepopulationof duode-
nal immunoglobulin A plasmocytes
inaxenicmiceassociatedwithdiffer-
entlivingordeadbacterialstrainsof
intestinal origin. Infect. Immun. 21,
532–539.
Nardi, R. M., Silva, M. E., Vieira, E.
C., Bambirra, E. A., and Nicoli,
J. R. (1989). Intragastric infection
of germfree and conventional mice
with Salmonella typhimurium. Braz.
J. Med. Biol. Res. 22, 1389–1392.
Niess, J. H., Leithauser, F., Adler, G.,
and Reimann, J. (2008). Commen-
sal gut ﬂora drives the expan-
sion of proinﬂammatory CD4 T
cells in the colonic lamina pro-
pria under normal and inﬂamma-
tory conditions. J. Immunol. 180,
559–568.
Ochoa-Reparaz, J., Mielcarz, D. W.,
Wang, Y., Begum-Haque, S., Das-
gupta,S.,Kasper,D.L.,andKasper,L.
H.(2010).Apolysaccharidefromthe
human commensal Bacteroides frag-
ilis protects against CNS demyeli-
nating disease. Mucosal Immunol. 3,
487–495.
Penders, J., Thijs, C., Vink, C., Stelma,
F.F.,Snijders,B.,Kummeling,I.,Van
Den Brandt, P. A., and Stobberingh,
E. E. (2006). Factors inﬂuencing the
composition of the intestinal micro-
biotainearlyinfancy. Pediatrics 118,
511–521.
Rask, C., Evertsson, S., Telemo, E.,
and Wold, A. E. (2005). A full
ﬂora, but not monocolonization by
Escherichia coli or lactobacilli, sup-
ports tolerogenic processing of a
www.frontiersin.org March 2012 | Volume 3 | Article 33 | 5Arrieta and Finlay The commensal microbiota drives immune homeostasis
fed antigen. Scand. J. Immunol. 61,
529–535.
Rescigno, M. (2011). The intestinal
epithelial barrier in the control of
homeostasis and immunity. Trends
Immunol. 32, 256–264.
Round, J. L., and Mazmanian, S. K.
(2009). The gut microbiota shapes
intestinal immune responses dur-
ing health and disease. Nat. Rev.
Immunol. 9, 313–323.
Sekirov, I., and Finlay, B. B. (2009). The
role of the intestinal microbiota in
enteric infection. J. Physiol. (Lond.)
587, 4159–4167.
Sekirov, I., Tam, N. M., Jogova, M.,
Robertson, M. L., Li,Y. L., Lupp, C.,
and Finlay, B. B. (2008). Antibiotic-
inducedperturbationsof theintesti-
nal microbiota alter host suscep-
tibility to enteric infection. Infect.
Immun. 76, 4726–4736.
Smith, K., Mccoy, K. D., and Macpher-
son, A. J. (2007). Use of axenic
animals in studying the adapta-
tion of mammals to their com-
mensalintestinalmicrobiota.Semin.
Immunol. 19, 59–69.
Sokol, H., Pigneur, B., Watterlot, L.,
Lakhdari, O., Bermudez-Humaran,
L. G., Gratadoux, J. J., Blugeon, S.,
Bridonneau, C., Furet, J. P., Cor-
thier, G., Grangette, C.,Vasquez, N.,
Pochart,P.,Trugnan,G.,Thomas,G.,
Blottiere, H. M., Dore, J., Marteau,
P.,Seksik,P.,and Langella,P. (2008).
Faecalibacterium prausnitzii is an
anti-inﬂammatory commensal bac-
terium identiﬁed by gut microbiota
analysis of Crohn disease patients.
Proc. Natl. Acad. Sci. U.S.A. 105,
16731–16736.
Sprinz, H., Kundel, D. W., Dammin, G.
J.,Horowitz,R.E.,Schneider,H.,and
Formal,S.B.(1961).Theresponseof
the germfree guinea pig to oral bac-
terial challenge with Escherichia coli
and Shigella ﬂexneri. Am. J. Pathol.
39, 681–695.
Strauch, U. G., Obermeier, F., Grun-
wald, N., Gurster, S., Dunger, N.,
Schultz, M., Griese, D. P., Mahler,
M., Scholmerich, J., and Rath, H. C.
(2005). Inﬂuence of intestinal bac-
teria on induction of regulatory T
cells: lessons from a transfer model
of colitis. Gut 54, 1546–1552.
Swidsinski, A., Loening-Baucke, V.,
Vaneechoutte, M., and Doerffel, Y.
(2008). Active Crohn’s disease and
ulcerative colitis can be speciﬁcally
diagnosed and monitored based on
the biostructure of the fecal ﬂora.
Inﬂamm. Bowel Dis. 14, 147–161.
Tap,J.,Mondot,S.,Levenez,F.,Pelletier,
E., Caron, C., Furet, J. P., Ugarte,
E.,Munoz-Tamayo,R.,Paslier,D. L.,
Nalin, R., Dore, J., and Leclerc, M.
(2009). Towards the human intesti-
nal microbiota phylogenetic core.
Environ. Microbiol. 11, 2574–2584.
Turnbaugh, P. J., Hamady, M., Yat-
sunenko, T., Cantarel, B. L., Dun-
can, A., Ley, R. E., Sogin, M. L.,
Jones, W. J., Roe, B. A., Affourtit, J.
P.,Egholm,M.,Henrissat,B.,Heath,
A. C., Knight, R., and Gordon, J. I.
(2009). A core gut microbiome in
obese and lean twins. Nature 457,
480–484.
Uematsu, S., Fujimoto, K., Jang, M. H.,
Yang,B.G.,Jung,Y.J.,Nishiyama,M.,
Sato, S., Tsujimura, T., Yamamoto,
M.,Yokota,Y.,Kiyono,H.,Miyasaka,
M., Ishii, K. J., and Akira, S. (2008).
Regulation of humoral and cellu-
lar gut immunity by lamina pro-
pria dendritic cells expressing Toll-
l i k er e c e p t o r5 .Nat. Immunol. 9,
769–776.
Umesaki, Y., Okada, Y., Matsumoto,
S., Imaoka, A., and Setoyama, H.
(1995). Segmented ﬁlamentous bac-
teriaareindigenousintestinalbacte-
ria that activate intraepithelial lym-
phocytes and induce MHC class-II
molecules and fucosyl asialo Gm1
glycolipids on the small-intestinal
epithelial-cells in the ex-germ-free
mouse. Microbiol. Immunol. 39,
555–562.
van der Waaij, D., Berghuis-De Vries,
J. M., and Lekkerkerk, L.-V. (1971).
Colonization resistance of the
digestive tract in conventional and
antibiotic-treated mice. J. Hyg.
(Lond.) 69, 405–411.
Wen, L., Ley, R. E., Volchkov, P. Y.,
Stranges,P. B.,Avanesyan,L.,Stone-
braker, A. C., Hu, C. Y., Wong,
F. S., Szot, G. L., Bluestone, J. A.,
Gordon, J. I., and Chervonsky, A.
V. (2008). Innate immunity and
intestinalmicrobiotainthedevelop-
mentof Type1diabetes.Nature 455,
1109–1113.
Willing, B., Halfvarson, J., Dicksved,
J., Rosenquist, M., Jarnerot, G.,
Engstrand, L., Tysk, C., and Jans-
son,J. K. (2009). Twin studies reveal
speciﬁc imbalances in the mucosa-
associated microbiota of patients
with ileal Crohn’s disease. Inﬂamm.
Bowel Dis. 15, 653–660.
Willing, B. P., Gill, N., and Finlay, B.
B. (2010). The role of the immune
system in regulating the microbiota.
Gut Microbes 1, 213–223.
Willing, B. P., Vacharaksa, A., Croxen,
M., Thanachayanont, T., and
Finlay, B. B. (2011). Altering
host resistance to infections
through microbial transplan-
tation. PLoS ONE 6, e26988.
doi:10.1371/journal.pone.0026988
Willing, B. P., and Van Kessel, A. G.
(2007). Enterocyte proliferation and
apoptosis in the caudal small intes-
tine is inﬂuenced by the composi-
tion of colonizing commensal bac-
teriaintheneonatalgnotobioticpig.
J. Anim. Sci. 85, 3256–3266.
Wlodarska, M., Willing, B., Keeney, K.
M., Menendez, A., Bergstrom, K. S.,
Gill,N.,Russell,S. L.,Vallance,B.A.,
and Finlay, B. B. (2011). Antibiotic
treatment alters the colonic mucus
layer and predisposes the host to
exacerbated Citrobacter rodentium-
induced colitis. Infect. Immun. 79,
1536–1545.
Wu, G. D., Chen, J., Hoffmann, C., Bit-
tinger, K., Chen, Y. Y., Keilbaugh, S.
A., Bewtra, M., Knights, D., Wal-
ters, W. A., Knight, R., Sinha, R.,
Gilroy, E., Gupta, K., Baldassano,
R., Nessel, L., Li, H., Bushman, F.
D., and Lewis, J. D. (2011). Linking
long-term dietary patterns with gut
microbial enterotypes. Science 334,
105–108.
Wu, H. J., Ivanov, Ii, Darce, J., Hattori,
K., Shima, T., Umesaki, Y., Littman,
D. R., Benoist, C., and Mathis, D.
(2010).Gut-residingsegmentedﬁla-
mentousbacteriadriveautoimmune
arthritis via T helper 17 cells. Immu-
nity 32, 815–827.
Zachar, Z., and Savage, D. C. (1979).
Microbialinterferenceandcoloniza-
tion of the murine gastrointesti-
nal tract by Listeria monocytogenes.
Infect. Immun. 23, 168–174.
Zaph, C., Du, Y., Saenz, S. A., Nair, M.
G., Perrigoue, J. G., Taylor, B. C.,
Troy,A. E.,Kobuley,D. E.,Kastelein,
R. A., Cua, D. J., Yu, Y., and Artis,
D. (2008). Commensal-dependent
expression of IL-25 regulates the IL-
23-IL-17 axis in the intestine. J. Exp.
Med. 205, 2191–2198.
Conﬂict of Interest Statement: The
authors declare that the research was
conducted in the absence of any com-
mercial or ﬁnancial relationships that
could be construed as a potential con-
ﬂict of interest.
Received: 01 December 2011; paper
pending published: 22 December 2011;
accepted: 14 February 2012; published
online: 05 March 2012.
Citation: Arrieta M-C and Finlay BB
(2012) The commensal microbiota dri-
ves immune homeostasis. Front. Immun.
3:33. doi: 10.3389/ﬁmmu.2012.00033
This article was submitted to Frontiers in
Molecular Innate Immunity, a specialty
of Frontiers in Immunology.
Copyright © 2012 Arrieta and Finlay.
This is an open-access article distributed
underthetermsoftheCreativeCommons
Attribution Non Commercial License,
which permits non-commercial use, dis-
tribution, and reproduction in other
forums,providedtheoriginalauthorsand
source are credited.
Frontiers in Immunology | Molecular Innate Immunity March 2012 | Volume 3 | Article 33 | 6